logo
Share SHARE
FONT-SIZE Plus   Neg

Covidien To Acquire Newport Medical Instruments For About $108 Mln - Quick Facts

Covidien plc. (COV) announced a definitive agreement to acquire Newport Medical Instruments, Inc, which is privately-owned and based in Costa Mesa, CA, for approximately $108 million.

The transaction, subject to customary closing conditions, including receipt of certain regulatory approvals, is expected to be completed in the second calendar quarter of 2012.

Newport Medical is a physician-led company, focused solely on the design and manufacture of dependable, life improving ventilators. Newport Medical's products are sold in the United States and more than 115 countries worldwide.

Assuming a closing in the second calendar quarter of 2012, Covidien said that it does not expect this transaction to have a material impact on its fiscal 2012 sales, operating margin or earnings per share.

Once the transaction has been completed, Covidien will report the Newport Medical business as part of its Airway & Ventilation product line in the Medical Devices segment.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
British drug maker AstraZeneca Plc reported Friday higher profit in its first quarter, reflecting lower charges and higher revenues. US and emerging markets performed well. Looking ahead, for fiscal 2016, the company continues to expect both revenue and earnings per share to decline a low to mid single-digit percentage at constant exchange rates. International Consolidated Airlines Group S.A. Friday reported profit for the first quarter, compared to loss in the prior year, mainly reflecting higher passenger revenues and increased capacity. For fiscal 2016, IAG still expects to generate an absolute operating profit increase similar to 2015 as it expects to reduce underlying ex-fuel unit costs by around one percent. French drug maker Sanofi reported Friday a higher profit in its first quarter, while net sales were hurt mainly by weak results in Diabetes unit and Venezuela. Excluding Venezuela. Aggregate Group sales increased 3 percent at constant exchange rates. Looking ahead, the company continues to expect 2016 business earnings per share to be broadly stable at CER.
comments powered by Disqus
Follow RTT